Old Mission Capital LLC Ironwood Pharmaceuticals Inc Transaction History

Old Mission Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$10.61 - $12.88 $1.91 Million - $2.31 Million	-179,706 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$10.86 - $13.95 $426,819 - $548,262	-39,302 Reduced 17.95%	179,706 $2.1 Million
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $1.06 Million - $1.23 Million	88,646 Added 68.0%	219,008 $2.86 Million
Q2 2021 Aug 13, 2021	BUY	$10.16 - $13.11 $1.32 Million - $1.71 Million	130,362 New	130,362 $1.68 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $539M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.